NCT06858501 2025-12-31Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk NeuroblastomaChildren's Oncology GroupPhase 2 Not yet recruiting84 enrolled
NCT04385277 2025-10-27Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)Children's Oncology GroupPhase 2 Active not recruiting41 enrolled 13 charts